Abstract
IntroductionPatients with COVID-19-related acute respiratory distress syndrome (ARDS) show limited systemic hyperinflammation, but immunomodulatory treatments are effective. Little is known about the inflammatory response in the lungs and if this...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have